Martin Shkreli heads into fraud trial

Pharmaceutical entrepreneur Martin Shkreli is headed to trial today.

Known for raising the price of a life-saving drug by 5,000 percent, Shkreli is accused of running a Ponzi-like scheme at his former hedge fund and a drug company he once ran.

The charges are not related to his infamous move to raise the price of anti-parisitic drug Daraprim to $750 a pill from $13.50 in 2015.

Read more from Reuters.